Elacytarabine
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Elacytarabine, covering 2013-08-28 to 2013-09-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia [Phase 2]